Autoimmunity & calming an over-active response
One of 5 mechanistic pathways to 🛡️ Immune resilience · 15 options
The opposite problem, and one that 'immune boosting' actively worsens. Here the goal is restoring regulatory T-cell function and resolving inflammation properly — modulation rather than stimulation, and the distinction is not academic.
Antibodies appear years before symptoms do. Thyroid antibodies in particular are worth knowing with a normal TSH, because they change how you'd approach iodine and selenium entirely.
ANA (Antinuclear Antibodies)Rheumatoid FactorThyroid Antibodies (TPO + TgAb)hs-CRP (High-Sensitivity C-Reactive Protein)ESR (Sed Rate)Vitamin D (25-Hydroxy)🛡️ Autoimmune Screen covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
💉 Low Dose Naltrexone
TLR4 antagonism plus endorphin rebound. Small trials in Crohn's, fibromyalgia and multiple sclerosis are encouraging; it is cheap, low-risk and badly under-studied.
💉 VIP
Shifts macrophages toward the M2 regulatory phenotype and induces regulatory T-cells.
💉 KPV
Anti-inflammatory at mucosal surfaces, with interest in inflammatory bowel disease.
💉 Thymosin Alpha 1
Modulates rather than stimulates, which is why it does not carry the autoimmune concern that true immune stimulants do.
🧬 Vitamin D
Promotes regulatory T-cell development. Deficiency is associated with multiple autoimmune conditions, and latitude gradients in MS incidence are among the strongest environmental signals in the field.
🧬 Omega-3 (Fish Oil)
Resolvin substrate; trial evidence for reduced disease activity in rheumatoid arthritis.
🧬 SPMs (Pro-Resolving Mediators)
The resolution signal itself — the mechanism that is supposed to end inflammation and fails to in chronic disease.
🧬 Curcumin
NF-κB inhibition with trial evidence in rheumatoid arthritis and ulcerative colitis.
🧬 Boswellia
5-LOX inhibition with trial data in inflammatory bowel disease and osteoarthritis.
🧬 Palmitoylethanolamide (PEA)
Mast-cell and glial modulation with a very clean safety profile.
🧬 UC-II Collagen
Oral tolerance induction — deliberately teaching the immune system to stop attacking a self-antigen. One of the most interesting mechanisms in supplement form.
🧬 Probiotic
Regulatory T-cell induction via the gut; the microbiome shapes systemic immune tolerance.
🧬 Selenium
Reduces thyroid peroxidase antibodies in Hashimoto's in several trials — a specific, measurable autoimmune endpoint.
🧬 NAC
Glutathione restoration in tissues under oxidative stress.
🧬 Luteolin
Mast-cell stabilisation, relevant in mast-cell activation presentations.
The other 4 routes to immune resilience
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
Want the protocols behind these?
Dosing schedules, stacking, cycle timing and Coach Cam's notes live inside the Academy — plus the full interactive Vault.
Join the Academy — $10/mo →← Open this pathway in the interactive Vault
Frequently asked questions
The opposite problem, and one that 'immune boosting' actively worsens. Here the goal is restoring regulatory T-cell function and resolving inflammation properly — modulation rather than stimulation, and the distinction is not academic.
15 options are mapped to this pathway in the Vault, including Low Dose Naltrexone, VIP, KPV, Thymosin Alpha 1. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 11 carry clinical validation and 4 are mechanistic predictions.
Antibodies appear years before symptoms do. Thyroid antibodies in particular are worth knowing with a normal TSH, because they change how you'd approach iodine and selenium entirely. The markers worth checking are ANA (Antinuclear Antibodies), Rheumatoid Factor, Thyroid Antibodies (TPO + TgAb), hs-CRP (High-Sensitivity C-Reactive Protein).
Unproven is not the same as ineffective. Of the 15 options on this pathway, 11 have clinical validation and 4 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.